How EU General Product Safety Regulation (GPSR) can impact your Pharma business?

EU GPSR (General Product Safety Regulation)

The EU General Product Safety Regulation (GPSR) is a regulatory framework in the European Union that aims to ensure that products placed on the market are safe for consumers. It applies to all products sold or distributed in the EU, whether manufactured locally or imported from other countries. The regulation is designed to protect consumers from harmful or defective products that do not meet safety standards.

Key aspects of EU GPSR include:

• General Safety Requirements: Products must meet certain safety standards before they are allowed to enter the market.
• Market Surveillance: Authorities are empowered to monitor the market for unsafe products and take corrective actions.
• Consumer Protection: The GPSR gives consumers the right to claim compensation if they are harmed by unsafe products.
• Traceability: Manufacturers and distributors must maintain records that allow the product's origin and supply chain to be traced in case of any safety concerns.

In the pharmaceutical industry, EU GPSR indirectly affects packaging, labeling, and the distribution of pharmaceutical products, especially when it comes to medical devices and over-the-counter products that may not fall under more specific medicinal regulations.

Vigilare Biopharma and How It Helps Pharma Companies

Vigilare Biopharma is a service provider that supports pharmaceutical companies in fulfilling their regulatory and compliance obligations, particularly related to pharmacovigilance (drug safety monitoring), risk management, and ensuring compliance with regulations like the EU GPSR and other safety standards.

Key ways Vigilare Biopharma helps pharma companies include:

1. Pharmacovigilance Support: Vigilare Biopharma helps companies monitor, detect, and assess the safety of their drugs once they are on the market, ensuring compliance with both EU and international drug safety regulations.
2. Regulatory Compliance: The company ensures that pharmaceutical products meet local and international regulatory requirements, such as the GPSR, Good Manufacturing Practice (GMP), and Good Distribution Practice (GDP).
3. Risk Management Plans (RMPs):We help in developing and implementing RMPs, which are essential in identifying and minimizing the risks associated with the use of pharmaceutical products.
4. Market Surveillance: Vigilare Biopharma monitors the market for adverse effects, reports safety data to authorities, and assists companies in taking corrective action when needed.
5. Training and Auditing: We offer training for pharma companies to ensure their teams are up to date with the latest regulatory requirements, and they audit internal processes to ensure compliance.

In summary, Vigilare Biopharma helps pharmaceutical companies ensure that their products meet safety and regulatory requirements, particularly with regard to drug safety and compliance, thus protecting both the company and consumers from potential risks.